|
|
|
|
|
|
|
Leaders in Poppy ProductionThe Tasmanian Poppy Industry was pioneered by Glaxo Australia in the early 1960s. It is one of the success stories of Australian agriculture and manufacturing.Founded with the objective of providing a reliable and secure source of opiate alkaloids, GlaxoSmithKline has grown to become one of the world's major suppliers, with an international reputation for security, reliability and quality. This growth has been based on the innovative development and usage of technology in all aspects of the operation, and has resulted in GlaxoSmithKline being recognised as the most cost-effective international producer. GlaxoSmithKline continues to pioneer advances in the industry, providing world markets with a reliable and secure source of alkaloids for analgesic medicines. Over 90% of the thebaine, codeine and morphine produced is sold to export markets. Innovation
GlaxoSmithKline leads the industry with:
Commercialisation of thebaine and Lontrel
Payment systems
Preparation
GlaxoSmithKline has undergone a managed expansion of crop area, combined with a balanced increase in drilling, harvesting and processing capacity. Success
GlaxoSmithKline has established a viable and successful industry for Tasmania - which leads the World for reliability and efficiency - and is based on:
The GlaxoSmithKline Poppy Operation is but one part of a World-wide operation. |
|
| © 2006 GlaxoSmithKline Australia Pty Ltd - All Rights Reserved |
|